2461.3000 -12.30 (-0.50%)
NSE Jan 01, 2026 09:18 AM
Volume: 963
 

2461.30
-0.50%
Prabhudas Lilladhar
GSK has given an optimistic growth outlook on the back of 1) double digit Change in Estimates | Target | Reco HFD volume growth in 9MFY19 2) uptick in rural demand post consumption friendly budget 3) success of Horlicks Protein Plus in fast growth protein...
GlaxoSmithKline Pharmaceuticals Ltd. is trading below all available SMAs
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended